参考文献/References:
[1] Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies[J]. Cell, 2019, 179(2): 312-339.
[2] Walsh DM, Klyubin I, Fadeeva JV, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo[J]. Nature, 2002, 416(6880): 535-539.
[3] Hong S, Beja-Glasser VF, Nfonoyim BM, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models[J]. Science, 2016, 352(6286): 712-716.
[4] Koffie RM, Meyer-Luehmann M, Hashimoto T, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques[J]. Proc Natl Acad Sci U S A, 2009, 106(10): 4012-4017.
[5] Ballatore C, Lee VM, Trojanowski JQ. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders[J]. Nat Rev Neurosci, 2007, 8(9): 663-672.
[6] Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-Amyloid in alzheimer’s disease[J]. Science, 2010, 330(612): 1774.
[7] Patterson BW, Elbert DL, Mawuenyega KG, et al. Age and amyloid effects on human central nervous system amyloid-beta kinetics[J]. Ann Neurol, 2015, 78(3): 439-453.
[8] Tarasoff-Conway JM, Carare RO, Osorio RS, et al. Clearance systems in the brain-implications for Alzheimer disease[J]. Nat Rev Neurol, 2015, 11(8): 457-470.
[9] Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β[J]. Sci Transl Med, 2012, 4(147): 147ra111.
[10] Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels[J]. Nature, 2015, 523(7560): 337-341.
[11] Cserr HF, Cooper DN, Suri PK, et al. Efflux of radiolabeled polyethylene glycols and albumin from rat brain[J]. Am J Physiol, 1981, 240(4): F319-F328.
[12] Cserr HF, Ostrach LH. Bulk flow of interstitial fluid after intracranial injection of blue dextran 2000[J]. Exp Neurol, 1974, 45(1): 50-60.
[13] Iliff J, Simon M. CrossTalk proposal: The glymphatic system supports convective exchange of cerebrospinal fluid and brain interstitial fluid that is mediated by perivascular aquaporin-4[J]. J Physiol, 2019, 597(17): 4417-4419.
[14] Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders[J]. Lancet Neurol, 2018, 17(11): 1016-1024.
[15] Nedergaard M. Garbage truck of the brain[J]. Science, 2013, 340(6140): 1529-1530.
[16] Ringstad G, Vatnehol S, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus[J]. Brain, 2017, 140(10): 2691-2705.
[17] Ringstad G, Valnes LM, Dale AM, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI[J]. JCI Insight, 2018, 3(13): 121537.
[18] Xu Z, Xiao N, Chen YL, et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits[J]. Mol Neurodegener, 2015, 10(1): 58.
[19] Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system?[J]. Stroke, 2013, 44(6, 1): S93-S95.
[20] Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain[J]. Science, 2013, 342(6156): 373-377.
[21] Shokri-Kojori E, Wang GJ, Wiers CE, et al. β-Amyloid accumulation in the human brain after one night of sleep deprivation[J]. Proc Natl Acad Sci U S A, 2018, 115(17): 4483-4488.
[22] Rainey-Smith SR, Mazzucchelli GN, Villemagne VL, et al. Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden[J]. Transl Psychiatry, 2018, 8(1): 47.
[23] Mestre H, Tithof J, Du T, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension[J]. Nat Commun, 2018, 9(1): 4878.
[24] Iliff JJ, Wang M, Zeppenfeld DM, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain[J]. J Neurosci, 2013, 33(46): 18190-18199.
[25] Serot J, Zmudka J, Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer’s disease[J]. Journal of Alzheimer’s Disease, 2012, 30(1):17-26.
[26] Silverberg GD, Mayo M, Saul T, et al. Alzheimer’s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis[J]. Lancet Neurol, 2003, 2(8): 506-511.
[27] Ma Q, Ineichen BV, Detmar M, et al. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice[J]. Nat Commun, 2017, 8(1): 1434.
[28] Pappolla M, Sambamurti K, Vidal R, et al. Evidence for lymphatic Aβ clearance in Alzheimer’s transgenic mice[J]. Neurobiol Dis, 2014, 71: 215-219.
[29] Aspelund A, Antila S, Proulx ST, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules[J]. J Exp Med, 2015, 212(7): 991-999.
[30] Ahn JH, Cho H, Kim JH, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid[J]. Nature, 2019, 572(7767): 62-66.
[31] Absinta M, Ha SK, Nair G, et al. Human and nonhuman Primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI[J]. Elife, 2017, 6: e29738.
[32] Zhou Y, Cai J, Zhang WH, et al. Impairment of the glymphatic pathway and putative meningeal lymphatic vessels in the aging human[J]. Ann Neurol, 2020, 87(3): 357-369.
[33] Da MS, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease[J]. Nature, 2018, 560(7717): 185-191.
[34] Patel TK, Habimana-Griffin L, Gao XE, et al. Dural lymphatics regulate clearance of extracellular tau from the CNS[J]. Mol Neurodegener, 2019, 14(1): 11.
[35] Mestre H, Mori Y, Nedergaard M. The brain’s glymphatic system: current controversies[J]. Trends Neurosci, 2020, 43(7): 458-466.
[36] Yu JT, Xu W, Tan CC, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials[J]. J Neurol Neurosurg Psychiatry, 2020,91(11):1201-1209.